A

ABL Bio Inc
KOSDAQ:298380

Watchlist Manager
ABL Bio Inc
KOSDAQ:298380
Watchlist
Price: 27 150 KRW 2.84% Market Closed
Market Cap: 1.3T KRW
Have any thoughts about
ABL Bio Inc?
Write Note

ABL Bio Inc
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ABL Bio Inc
Retained Earnings Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
A
ABL Bio Inc
KOSDAQ:298380
Retained Earnings
-â‚©365.7B
CAGR 3-Years
-10%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Retained Earnings
â‚©4T
CAGR 3-Years
10%
CAGR 5-Years
16%
CAGR 10-Years
17%
SK Bioscience Co Ltd
KRX:302440
Retained Earnings
â‚©549.4B
CAGR 3-Years
118%
CAGR 5-Years
127%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Retained Earnings
â‚©1T
CAGR 3-Years
6%
CAGR 5-Years
6%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Retained Earnings
â‚©324.4B
CAGR 3-Years
31%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Retained Earnings
â‚©23.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

ABL Bio Inc
Glance View

Market Cap
1.3T KRW
Industry
Biotechnology

ABL Bio, Inc. engages in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2018-12-19. The major products include anti-angiogenesis antibodies anti-tumor targeting antibodies, T cell engager bispecific antibodies (TCEs), dual immune cell targeting bispecific antibodies (DICs), novel immune cell targeting antibodies (NICs), brain disease dual antibodies, antibody-drug conjugates (ADCs) , among others.

Intrinsic Value
8 401.38 KRW
Overvaluation 69%
Intrinsic Value
Price
A

See Also

What is ABL Bio Inc's Retained Earnings?
Retained Earnings
-365.7B KRW

Based on the financial report for Jun 30, 2024, ABL Bio Inc's Retained Earnings amounts to -365.7B KRW.

What is ABL Bio Inc's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
-14%

Over the last year, the Retained Earnings growth was -5%. The average annual Retained Earnings growth rates for ABL Bio Inc have been -10% over the past three years , -14% over the past five years .

Back to Top